Nonwovenn, one of the world’s leading nonwoven fabric-tech companies, has announced significant advancements in its activated carbon (AC) fabric technology, improving AC accessibility, performance and manufacturing robustness across its certified face mask ranges.
The latest developments focus on enhancing processing systems that enable greater AC accessibility, resulting in improved filtration performance, manufacturing consistency and product value.
Through the refined processing systems, Nonwovenn has optimised how activated carbon is integrated and exposed within the mask fabric structure, ensuring high adsorption efficiency and longer service life. The business has also made advancements in bonding and lamination techniques, AC and fibre distribution control and layer architecture. The innovations help make the manufacturing process more stable and scalable, reduces waste and improves quality consistency.
Dr Ross Ward, CarbonTech Business Director at Nonwovenn, said: “We are continually developing new ways to make our activated carbon systems more accessible and effective. By refining how AC is incorporated and exposed within our fabric structures, we are seeing measurable improvements in both performance and process stability, which translates into stronger customer value and product competitiveness.”
“Our customers will benefit from improved carbon utilisation, enhanced manufacturing processability, consistent carbon containment, flexible construction options and clear alignment with current PPE and medical standards. These developments help reinforce our customer first approach, as we are always looking at ways we can improve our products.”
Nonwovenn’s certified mask fabrics are designed to meet recognised standards such as EN 149 for particle-filtering half masks under the European PPE Regulation, and relevant medical device standards where applicable. The products provide consistent protection and traceability for both occupational and clinical use. Alongside these certified face mask fabric options, Nonwovenn continues to offer mask fabrics that deliver comfort, odour control and protection from volatile organic compounds found in everyday environments. The business has also introduced selective additive and catalyst enhancements that broaden adsorption profiles for volatile organic compounds.
Nonwovenn, one of the world’s leading nonwoven fabric-tech companies, has announced its 19th consecutive year of profitable growth, marking another milestone in the company’s journey of investment, innovation and global expansion.
For the 2024/25 financial year, Nonwovenn delivered revenues of £45 million, which represented a 25% increase in sales year-on-year. The strong performance has been driven in part by double digit growth in its PouchTech and ProTech business units. Alongside this growth, the business has welcomed over 50 new members of staff, reflecting the level of investment and scale of expansion.
The record year comes off the back of Nonwovenn’s extensive three-year transformation programme, which has seen more than £10 million investment into a new ‘operational excellence model’ including investment in manufacturing equipment, an end-to-end operational efficiency programme and an enhancement in R&D and innovation capability. The past few months have also seen the conversion of existing chemical bond lines and the purchase of a further new line. A further £4 million of investment has been committed to support further growth, with an ambitious target to grow revenues in this financial year to £60 million.
As part of the innovation and growth strategy, Nonwovenn has also launched a brand-new business unit, CarbonTech. This is focused on activated carbon technology, which compliments the existing capabilities across as ProTech, MediTech, InduTech and PouchTech. This diversification reinforces the businesses position as an industry leader.
With sustainability high on the sector agenda, Nonwovenn is leading the industry having been awarded the gold medal by EcoVadis, at first attempt, in March 2025. This means it is ranked in the top 5% globally across over 130,000 companies. Nonwovenn is also recognised for excellence in environment, labour and human rights, ethics, and sustainable procurement.
Nonwovenn’s Commercial Director, Silke Brand added: “To have delivered 24% sales growth this year is something we are incredibly proud of. It is a testament to the innovation, investment and talent that runs through Nonwovenn. We are continuing to invest in our facilities, technology and people in the coming years and hope to continue this sustained growth. We have strong momentum across all our sectors and markets, and further growth is planned across the board in people, performance and investment.”
“The past year has been transformational for Nonwovenn, especially with the levels of investment and growth we have secured. The launch of the new CarbonTech business unit will also open up some new and exciting opportunities. Pair this with the internationalisation strategy and we are in a very strong position to continue leading the industry and being the partner of choice for businesses across the world.”
Nonwovenn is continuing to focus on the high-value, high growth segments, with future expansion plans targeting the Middle East, Far East and India, in addition to furthering the presence across all current areas.
Nonwovenn, one of the world’s leading nonwoven fabric-tech companies, has announced a significant investment in its MediTech division. The latest investment includes a new state-of-the-art medical manufacturing suite at its Bridgwater headquarters.
This strategic investment marks a major milestone in Nonwovenn’s three-year growth plan, which aims to deliver 14% year-on-year growth from its MediTech division, through the innovation pipeline, strategic partnerships and global footprint expansion.
The newly commissioned medical manufacturing facility features controlled environments that are purpose-built for precision manufacturing and includes a ‘Class 8’ standard performing cleanroom which is designed to meet even the most stringent medical industry standards. This development was supported by a joint investment from a key customer in the sector and underlines the strength of Nonwovenn’s collaborative approach to partnerships and the overall trust that is placed in the businesses long-term vision.
The research and development team have also delivered several high-impact innovations launched over the last year. These include x-ray detectable materials to enhance safety and traceability in surgical applications, and reinforced CMC hydrofibre for improved durability and absorption in wound care. The team have also developed a translucent nonwoven solution for use as a surgical site dressing scaffold to allow for visual inspection of incision sites without the need to remove the dressing. All three product innovations come as a direct result of world class research and development programmes to support client needs.
Alongside the investment in infrastructure and product advancements, Nonwovenn has strengthened its team with the appointment of Ross Ward as Business Director of Carbon. Ross is a leading expert in carbon technologies, and his expertise is already accelerating innovation in areas such as ostomy care and odour control.
John Birkett, Medical Business Director at Nonwovenn, said: “We are very proud to be able to strengthen our capabilities in advanced medical materials thanks to this world-class suite. The investment reflects our commitment to quality, innovation and continuing to serve the evolving needs of our partners in the sector across the UK, Europe and Middle East.”
Nonwovenn’s Commercial Director, Silke Brand added: “Our growth in the MediTech sector is not just about the facilities or the product, it’s about the lasting improvements it can make to patient care and outcomes. We are really working to shape the future of medical textiles, and this investment will help us achieve that.”
One of the world’s leading nonwoven fabric-tech companies, Nonwovenn has announced it is investing in innovation, research and development for technical fabrics in high-growth areas. This includes activated carbon filtration, coalescer filtration and acoustic solutions. The strategic investment will form part of the company’s broader expansion plans, supporting its ambition to increase its market share and technical capabilities.
The next phase of targeted investment follows an extensive £13 million business-wide transformation programme which has included significant self-funded capex investment in manufacturing, plant and equipment. It also involved an end-to-end operational efficiency programme and an enhancement in R&D and innovation capability, to enable the servicing of growing order volumes.
To support key growth areas in this sector the investment includes upgrading the current impregnation line as well as introducing a second, doubling output capacity. Nonwovenn is also expanding its team to introduce a wider range of technically advanced respiratory protection and air and liquid filtration solutions.
Alongside this Nonwovenn is also advancing its coalescer filtration technology, which separates liquids from other liquids or gasses, for example in compressed air systems to remove oil droplets and fine particles. With strong partnerships already in place and exciting new opportunities in the near future, Nonwovenn is looking to double sales over the next 12 to 18 months.
In addition, the business is also advancing its acoustic solutions for ceiling / wall panels and automotive, which is a new product offering that has been developed and launched to the market. It offers a noise reduction coefficient of up to 0.85 without the use of any mineral or fiberglass mats. Plans are in place to expand in this area by 70% over the next three years to meet the increasing demand
Looking ahead to the next 24 months, Nonwovenn is also exploring opportunities within the cable industry, which will see focus placed on the development of swellable and semiconductive nonwoven materials.
Fabrizio Tiribilli, Industrial Business Director at Nonwovenn, said: “InduTech is a key growth area for Nonwovenn. Our investments in filtration and acoustics reflect commitment to innovation and technical excellence. By increasing capacity, efficiency, and driving forward product development, we’re adapting to the needs of our customers in this growing market.”
Nonwovenn chairman, David Lamb added; “The latest phase of investment is another step towards our goal of becoming the market leader across our four market vehicles. The outlook in the industrial sector is incredibly promising, and we’re excited to see what happens next.”
One of the world’s leading nonwoven fabric-tech companies, Nonwovenn is investing £1.5 million in its ProTech division to strengthen its market-leading position in personal protection and harm reduction. The investment is part of a long-term growth strategy, with a business unit target of £16 million turnover by 2028.
A major focus of the investment is in the research and development of CBRN (chemical, biological, radiological, and nuclear) protective solutions for first responder and military safety and protective clothing. Nonwovenn is also working closely with ministries of defence, and first responders across the globe.
To support this ambitious growth, Nonwovenn has strengthened its specialist team with four key appointments, expert recruits with considerable understanding and experience.
Nonwovenn is therefore, also making significant strides in product innovation, with new CBRN solutions set to launch throughout 2025 and 2026. Among these are advancements in protection systems for firefighters focused on volatile organic compound (VOC) filtration, as well as next-generation protective solutions tailored towards military and first responders.
Andrew Fisher, Head of ProTech at Nonwovenn, said: “This is an exciting time at Nonwovenn. Not only are we investing in cutting-edge R&D, but we’re also building a strong team to bring these innovations to market and fully support our customers. By combining our advanced technology with real-world application insight, we are setting new standards in personal protection and harm reduction.”
Nonwovenn chairman, David Lamb added; “Our focus on growth, innovation and talent acquisition reflects our commitment to advancing protective solutions for the industries that need them most. With our ambitious R&D programme, strategic partnerships and industry-leading team, we’re confident in our ability to become the leading player in this segment of the market.”
Nonwovenn offer complete support to customers working intimately with them on new concepts, through innovation, product design, business development, commercialisation and supply of products, offering complete ‘end to end’ supply expertise. This ranges from ‘live chemical’ agent instruction, and fully planned and audited supply chain management for large and small projects in addition to its outstanding expanding portfolio of products.
One of the world’s leading nonwoven fabric-tech companies, Nonwovenn has announced it is investing a further £5 million of self-funded capex to support the next phase of expansion and development.
The latest investment follows the completion of the first phase of the business’ transformation programme, which has seen £13m invested into a new ‘operational excellence model’ including investment in manufacturing equipment, an end-to-end operational efficiency programme and an enhancement in R&D and innovation capability.
The second phase of investment will be focused on capacity increases and improved capability. 2025/26 will see a focus on chemical bond production, with a significant increase in volume through conversion of existing lines and the purchase of a new line. The enhanced capability is to support the businesses ambitious growth targets in the $5.5 billion global oral pouch delivery sector.
Investments in operational management capability have already begun, with a new Operations Director and Operations Manager appointed to the business and doubling the number of shift managers. The senior team are working with planning, health and safety and quality teams to ensure the current and new staff are fully supported with training and development opportunities. There has also been a 50 person increase in manufacturing recruitment, which combined with the launch of a new multi skilling programme is designed to underpin the growth ambition.
Commenting on the new growth phase, David Lamb, chairman of Nonwovenn said; “We have seen substantial growth and transformation from the first phase of investment. The additional £5 million reaffirms our commitment to driving innovation, efficiency and sustainability at Nonwovenn.”
“The shift to focus more on chemical bond in 2025/26 marks a significant milestone, boosting our current capacity and a further 25% added when the new line is complete. The business is truly evolving, and we’re incredibly excited about what the future holds.”
Operations Director, Neil Thorn added; “We have had significant operational and performance improvements through the investment made in phase one of our programme. It is very exciting to see the the Operational Excellence journey gaining momentum through investment in equipment and new management talent. This additional funding will allow us to bring people and operational excellence to the forefront of the business to support the levels of growth we are aiming for.”
One of the world’s leading nonwoven fabric-tech companies, Nonwovenn has announced ambitious plans targeting substantial revenue growth in the oral pouch delivery market, estimated to be worth $5.5 billion globally, with an annual growth rate of 30%.
The businesses’ PouchTech division has already seen its market share of fabric supply in this sector grow substantially, and is looking to further expand its reach over the next three years. The ambitious target follows an extensive £13 million business transformation programme which has included significant self-funded capex investment in manufacturing, plant and equipment, an end-to-end operational efficiency programme and an enhancement in R&D and innovation capability, to enable the servicing of growing order volumes.
Over the last 20 years Nonwovenn has built a world-wide reputation for supplying the finest technical fabrics used in the manufacture of oral pouch products, with the aim of producing the best rapid flavour transfer and oral experience for adult consumers.
Five years ago, the business took a strategic decision to refocus the supply of fabrics for tobacco related products, now focusing on modern oral nicotine pouches supporting smoking cessation and pouches used in the delivery of other stimulants such as caffeine, as well as agents like CBD and nutritional supplements.
Dr Adrian Bisson, Head of PouchTech at Nonwovenn, said: “This transformative focus on modern oral pouch technology reflects our commitment to sustainability, harm reduction and meeting the evolving needs of adult consumers. By focusing on rapid flavour release, oral comfort and the highest standards of quality assurance, Nonwovenn is ensuring our products meet the highest standards and deliver superior customer experiences.”
“To ensure our products are safe and of high quality, the materials are independently certified for food contact approval through a world-renowned testing institution. We actually set the standard for modern oral pouches, with many product manufacturers now insisting pouch fabric suppliers meet that same standard and certification.
Nonwovenn chairman, David Lamb added; “We are working towards positioning ourselves as the market leader in this rapidly growing sector. We are not just advancing modern oral alternatives; we are building a pathway to a broader range of products that help reflect our commitment to sustainability, health and harm reduction.”
One of the world’s leading nonwoven fabric-tech companies, Nonwovenn has recently achieved a major milestone of 18 years of consecutive profitable growth with the current financial year delivering a turnover of £45m with a 20%+ EBITDA and sees the business now targeting an ambitious goal of growing turnover to £80m by 2028.
The 4-year growth plan comes off the back of an extensive £13m business transformation programme which has included significant self-funded capex investment in manufacturing plant and equipment, an end-to-end operational efficiency programme and an enhancement in R&D and innovation capability.
In addition, the executive team has been strengthened with senior appointments across finance, HR, operations and sustainability, with the most recent appointment being industry luminary Silke Brand-Kirsch as commercial director, who will be spearheading the internationalisation and growth strategy.
The focus for the next 4 years is to build upon the businesses leading position in niche, high value, high growth segments established in markets across the UK, Europe and North America, as well as delivering to a broader global audience. Central to the businesses value proposition will be an increased focus on innovating and delivering world class technical fabrics that are used in products that enable harm reduction across every aspect of life.
Commenting on the growth trajectory, David Lamb, chairman of Nonwovenn said; “To have 18 out of our 21 years be profitable is something many businesses only dream about. We are incredibly proud that even in a sector that is under so much pressure, we have continuously achieved profitable and sustainable growth. It is largely thanks to the investments made in the business to improve our products, streamlining our systems, and the market leading board we have built.”
“We are looking to double our turnover in the next three to four years, with profits growing at a similar rate. We chose to create a new board to drive this growth forward and bring in the expertise needed to enable the internationalisation we are aiming for. It’s a very exciting time for the business and we cannot wait to see where the next few years take us.”
Commercial director, Silke Brand-Kirsch added; “We are really looking to expand into the North American and European markets initially, and then look to branch out even further. Our offering plugs a gap in the market, and with our leading research and development, expert board team and focus on sustainable and innovative growth we can continue to give the market exactly what they need.”